HPRA Drug Safety Newsletter 97th Edition

Download: hpra-drug-safety-newsletter-97th-edition.pdf 434 KB

 The latest edition of the HPRA Drug Safety Newsletter is a dedicated issue reminding healthcare professionals (HCPs) of the serious teratogenic risks of valproate-containing medicines (Epilim), restrictions for use, contraindication in women of childbearing potential and in pregnancy, details of the pregnancy prevention programme and important individual actions required of each HCP. 



« Back